ID | 110830 |
Author |
Seike, Junichi
Department of Oncological and Regenerative Surgery, Institute of Health Bioscience, The University of Tokushima Graduate School
Yoshida, Takahiro
Department of Oncological and Regenerative Surgery, Institute of Health Bioscience, The University of Tokushima Graduate School
KAKEN Search Researchers
Honda, Junko
Department of Oncological and Regenerative Surgery, Institute of Health Bioscience, The University of Tokushima Graduate School
Miyoshi, Takanori
Department of Oncological and Regenerative Surgery, Institute of Health Bioscience, The University of Tokushima Graduate School
Umemoto, Atsushi
Department of Oncological and Regenerative Surgery, Institute of Health Bioscience, The University of Tokushima Graduate School
Tangoku, Akira
Department of Oncological and Regenerative Surgery, Institute of Health Bioscience, The University of Tokushima Graduate School
Tokushima University Educator and Researcher Directory
KAKEN Search Researchers
|
Keywords | esophageal cancer
chemotherapy
lung metastasis
|
Content Type |
Journal Article
|
Description | A 55-year-old-male patient underwent subtotal esophagectomy for esophageal cancer (pT1b, N0, M0, stage II) in April 2005. The patient received postoperative chemotherapy (docetaxel 40 mg/body, 5-fluorouracil 750 mg/body, cisplatin 10 mg/body : administered every 4 weeks) for 3 months. Six months postoperatively, routine follow up CT demonstrated multiple metastatic tumors in the bilateral lungs. Under the diagnosis of multiple lung metastases, the patient was hospitalized and received intensive chemotherapy with docetaxel 40 mg/ week (day 1), 5-fluorouracil 500 mg/ day (days 1-5), cisplatin 10 mg/ day (days 1-5). After two weeks administration, the patient eagerly hoped for outpatient treatment. The treatment was changed to outpatient chemotherapy with S-1 100 mg/ day (continuous administration for 3 weeks followed by rest for 1 week) and cisplatin 20 mg/ every week. The treatment enabled the patient to keep working. Follow up CT showed disappearance of all tumors two months after TS-1/cisplatin chemotherapy. There were no obvious signs of recurrence 5 months after chemotherapy. The S-1/cisplatin therapy in the outpatient was thought to be one of the effective treatments in maintaining quality of life for the patient.
|
Journal Title |
The journal of medical investigation : JMI
|
ISSN | 13431420
|
NCID | AA11166929
|
Volume | 53
|
Issue | 3-4
|
Start Page | 321
|
End Page | 324
|
Sort Key | 321
|
Published Date | 2006-08
|
EDB ID | |
FullText File | |
language |
eng
|
TextVersion |
Publisher
|
departments |
University Hospital
Medical Sciences
|